In this trial, axokine resulted in an average weight loss of 2.9 kg, as compared to an average weight loss of 1.1 kg with placebo
Sikirics group has since become the dominant publisher of BPC-157 research, a point with implications for evaluating the evidence base
The compound was first described in the 1990s by Predrag Sikiric and colleagues at the University of Zagreb, Croatia
Safety Harbor (Tampa), Florida
BPC 157 is derived from gastric protein and may assist in healing various tissues, while TB 500 is a synthetic fragment of actin that focuses on cellular repair
Our cutting-edge therapies, including peptide therapy, stem cell therapy, and PRP (Platelet-Rich Plasma) therapy, are designed to treat fibromyalgia and enhance joint health